Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÁøÁ¤¹ýÀ» ÀÌ¿ëÇÑ Ä¡°ú Ä¡·á ½Ã ¼Ò¾Æ ȯÀÚÀÇ ÁøÁ¤ ÈÄ ¹ÝÀÀ¿¡ ´ëÇÑ ¿¬±¸

POSTSEDATION EVENTS IN PEDIATRIC PATIENTS SEDATED FOR DENTAL TREATMENT

´ëÇѼҾÆÄ¡°úÇÐȸÁö 2009³â 36±Ç 2È£ p.209 ~ 216
±¸Á¤Àº, ¹é±¤¿ì,
¼Ò¼Ó »ó¼¼Á¤º¸
±¸Á¤Àº ( Koo Jung-Eun ) - ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ ¸ñµ¿º´¿ø ¼Ò¾ÆÄ¡°úÇб³½Ç
¹é±¤¿ì ( Baek Kwang-Woo ) - ¾ÆÁÖ´ëÇб³ ÀÇ°ú´ëÇÐ Ä¡°úÇб³½Ç

Abstract

Chloral Hydrate¿Í hydroxyzineÀ» °æ±¸ º¹¿ëÇÑ ÈÄ midazolamÀ» ÇùÁ¡¸·ÇÏ·Î Ãß°¡ Åõ¿©ÇÑ ÁøÁ¤¹ýÀº ÁøÁ¤ ½Éµµ¸¦ ±í°Ô ÇØÁÖ°í ¾ÈÁ¤ÀûÀÎ ÁøÁ¤ »óŸ¦ À¯ÁöÇØ ÁØ´Ù°í º¸°íµÈ´Ù. ÁøÁ¤ Áß ³ªÅ¸³ª´Â ¹ÝÀÀ¿¡ ´ëÇÑ ¿¬±¸´Â È°¹ßÇϳª Åð¿ø ±âÁØ¿¡ µû¶ó ȯÀÚ¸¦ ±Í°¡½ÃŲ ÈÄ ³ªÅ¸³ª´Â ¹ÝÀÀ¿¡ ´ëÇÑ ¿¬±¸´Â ¾ÆÁ÷ ºÎÁ·ÇÏ´Ù. ÀÌ ¿¬±¸¿¡¼­´Â ÁøÁ¤¹ýÀ» ÀÌ¿ëÇÏ¿© Ä¡°ú Ä¡·á¸¦ ¹ÞÀº ¼Ò¾Æ ȯÀÚÀÇ ÁøÁ¤ ÈÄ Çൿ ¹ÝÀÀ ¹× ºÎÀÛ¿ë¿¡ ´ëÇØ ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù. ÀÌÈ­¿©ÀÚ´ëÇб³ ¸ñµ¿º´¿ø ¼Ò¾ÆÄ¡°ú¿¡ 2005³â 4¿ùºÎÅÍ 2007³â 12¿ù±îÁö ³»¿øÇÏ¿© ÁøÁ¤¹ýÀ¸·Î Ä¡·á¹ÞÀº ȯ¾Æ¸¦ ´ë»óÀ¸·Î ±Í°¡ ÈÄ 24½Ã°£ À̳»¿¡ ÀüÈ­¸¦ ÀÌ¿ëÇÏ¿© ¼³¹® Á¶»çÇÏ¿´´Ù. Á¶»ç Ç׸ñÀº ÁøÁ¤ Èļö¸é À¯¹«, ÁøÁ¤ ÈÄ ¼ö¸é ½Ã°£, ÁøÁ¤ ÈÄ ¼ö¸é Çൿ, ¼ö¸é¿¡¼­ ȸº¹ ÈÄ Çൿ, ÁøÁ¤ ÈÄ ±¸Åä À¯¹«ÀÌ´Ù. ±Í°¡ ÈÄ 227¸í(57.8%)ÀÌ ÀáÀ» Àä°í 21¸í(6.3%)ÀÌ ºñÁ¤»óÀûÀÎ ¼ö¸é ÇൿÀ» º¸¿´´Ù. 104¸í(31.0%)ÀÌ ¼ö¸é¿¡¼­ ȸº¹ ÈÄ ºñÁ¤»óÀûÀÎ ÇൿÀ» ÇÏ¿´°í, 10¸í(3.0%)ÀÌ ±¸Åä ¹ÝÀÀÀ» º¸¿´´Ù. Midazolam ¿ë·®ÀÌ ¸¹À¸¸é ÁøÁ¤ ÈÄ ÀáÀ» Àß °¡´É¼ºÀÌ Å©°í(p<0.05), ±«·Î¿ö Çϸ鼭 Àڰųª ÀÚ´Ù±ú´Ù¸¦ ¹Ýº¹ÇÒ ¼ö ÀÖÀ¸¸ç(p=0.055) ¼ö¸é ½Ã°£µµ ±æ¾îÁú ¼ö ÀÖ´Ù(p=0.054). À̹ø Á¶»ç¿¡¼­´Â ÁøÁ¤ ÈÄ ¼ö¸éÀÌ ¸¹¾Ò°í, ºñÁ¤»óÀûÀÎ Çൿ ¹× ±¸Åä ¹ÝÀÀµµ ÀÖ¾úÀ¸³ª ¿ì·ÁÇÒ ¸¸ÇÑ ÀÀ±Þ»óȲÀº ³ªÅ¸³ªÁö ¾Ê¾Ò´Ù. MidazolamÀÇ ÇùÁ¡¸·ÇÏ º´¿ë Åõ¿©´Â ¾ÈÀüÇÑ ÁøÁ¤¹ýÀ¸·Î º¸À̸ç Àå±âÀû ¿¬±¸, ÀüÇâÀû ¿¬±¸ µîÀÌ ÇÊ¿äÇÒ °ÍÀÌ´Ù.

The purpose of this retrospective study was to examine twenty four hour postsedation events after discharge in children sedated for dental treatment. The sedation sheets of 355 children were selected. Selection criteria excluded no midazolam or nasal route of midazolam, no ASA class I, absent or incomplete questionnaire. Children received orally chloral hydrate and hydroxyzine, nitrous oxide was maintained during the sedation. Midazolam was injected to buccal submucosa with titration. Parents were interviewed via telephone within twenty four hours after sedation. Questionnaire included sleeping response, sleeping time, sleeping behavior, vomiting response at home. Two hundred twenty four (67.8%) children slept and twenty one(6.3%) children had abnormal sleeping behavior. One hundred four(31.0%) children had abnormal behavior after sleep and ten(3.0%) children had vomiting response. In the children took the higher dose of midazolam, there were the great tendency to sleep after discharge (p<0.05), the more negative response to sleeping behavior(p = 0.055), the longer sleeping time(p=0.054). In this study many children slept after sedation and a few children showed negative response. However there were not any considerable emergency events. Further study is required to determine the postsedation safety for the use of submucosal midazolam combination with chloral hydrate and hydroxyzine.

Å°¿öµå

ÁøÁ¤ ÈÄ ¹ÝÀÀ;ºÎÀÛ¿ë
Postsedation response;Midazolam;Adverse effect

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI